StockNews.AI
BDX
StockNews.AI
195 days

BD Reports First Quarter Fiscal 2025 Financial Results

1. BDX reported Q1 revenue of $5.2 billion, a 9.8% increase. 2. BDX raised FY25 adjusted EPS guidance amidst strong earnings growth.

2m saved
Insight
Article

FAQ

Why Bullish?

The strong revenue and adjusted EPS guidance could attract investors, similar to prior positive earnings reports that boosted BDX's stock price.

How important is it?

Strong earnings can significantly influence market perceptions and stock performance, suggesting a solid foothold for BDX in the medical technology sector.

Why Short Term?

The immediate positive earnings impact on BDX price is likely, akin to past quarterly results correlating with short-term price increases.

Related Companies

BDXMDTSYK
Company Delivers Revenue, Margin and Earnings Ahead of its Expectations Revenue of $5.2 billion increased 9.8% as reported, 9.6% currency-neutral and 3.9% organic GAAP and adjusted diluted EPS of $1.04 and $3.43 grew 8.3% and 28.0%, respectively BD completes $750 million share repurchase to date in FY25 Company increases FY25 adjusted diluted EPS guidance at the midpoint while absorbing translational currency1 FRANKLIN LAKES, N.J. , Feb. 5, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its fiscal 2025 first quarter which ended December 31, 2024.

Related News